Dosing of atorvastatin and increases in fibrinogen level

Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.

The Journal of clinical endocrinology and metabolism·2012

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Journal of internal medicine·2006

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.

European heart journal·2002

Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.

Annals of internal medicine·2001

Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.

Annals of epidemiology·2001

Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile.

Circulation·2001

Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies.

Atherosclerosis·2026

The benefit of LDL-C levels below 55 mg/dL in ESKD patients under statin treatment: A target trial emulation study.

Atherosclerosis·2026

Roles of primary cilia in cardiovascular diseases: mechanisms and therapeutic prospects.

Atherosclerosis·2026

Discordant fatty acid profile drives residual inflammatory risk in metabolically vulnerable patients with low atherogenic lipoprotein burden.

Atherosclerosis·2026

The COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion.

Atherosclerosis·2026

Ultrasound-detected fatty liver in young adults and long-term risk of atherosclerotic cardiovascular disease: The Young Finns Study.

Atherosclerosis·2026

GENETIC AND PHARMACOLOGIC ACTIVATION OF BECLIN1 PREVENTSALDOSTERONE-INDUCED CARDIOVASCULAR DAMAGE.

Clinical science (London, England : 1979)·2026

From atherosclerosis to reperfusion injury: a comprehensive review of neutrophil extracellular traps across the spectrum of coronary heart disease.

The Journal of pathology·2026

Lower noradrenaline-mediated mean arterial pressure target in patients with acute myocardial infarction-related cardiogenic shock: rationale and design of the NORshock study.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Sex differences in computed tomography-derived fractional flow reserve-guided management of stable coronary artery disease: a subgroup analysis of the TARGET trial.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Multimodality imaging for pre-, intra-, and postprocedural guidance of left atrial appendage closure: a European Left Atrial Appendage Closure Club (ELAACC) expert consensus statement.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Reduced-dose direct oral anticoagulant versus antiplatelet strategies after left atrial appendage occlusion.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Related Experiment Videos

Dosing of atorvastatin and increases in fibrinogen level

Related Concept Videos

Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: results from the Cardiovascular Health Study.

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.

Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.

Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.

Treatment of isolated systolic hypertension is most effective in older patients with high-risk profile.

Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies.

The benefit of LDL-C levels below 55 mg/dL in ESKD patients under statin treatment: A target trial emulation study.

Roles of primary cilia in cardiovascular diseases: mechanisms and therapeutic prospects.

Discordant fatty acid profile drives residual inflammatory risk in metabolically vulnerable patients with low atherogenic lipoprotein burden.

The COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion.

Ultrasound-detected fatty liver in young adults and long-term risk of atherosclerotic cardiovascular disease: The Young Finns Study.

GENETIC AND PHARMACOLOGIC ACTIVATION OF BECLIN1 PREVENTSALDOSTERONE-INDUCED CARDIOVASCULAR DAMAGE.

From atherosclerosis to reperfusion injury: a comprehensive review of neutrophil extracellular traps across the spectrum of coronary heart disease.

Lower noradrenaline-mediated mean arterial pressure target in patients with acute myocardial infarction-related cardiogenic shock: rationale and design of the NORshock study.

Sex differences in computed tomography-derived fractional flow reserve-guided management of stable coronary artery disease: a subgroup analysis of the TARGET trial.

Multimodality imaging for pre-, intra-, and postprocedural guidance of left atrial appendage closure: a European Left Atrial Appendage Closure Club (ELAACC) expert consensus statement.

Reduced-dose direct oral anticoagulant versus antiplatelet strategies after left atrial appendage occlusion.

Related Experiment Videos

Dosing of atorvastatin and increases in fibrinogen level

Related Concept Videos

Related Articles